CN112870426A - Absorbent article comprising lotion composition and the lotion composition - Google Patents
Absorbent article comprising lotion composition and the lotion composition Download PDFInfo
- Publication number
- CN112870426A CN112870426A CN202011358216.7A CN202011358216A CN112870426A CN 112870426 A CN112870426 A CN 112870426A CN 202011358216 A CN202011358216 A CN 202011358216A CN 112870426 A CN112870426 A CN 112870426A
- Authority
- CN
- China
- Prior art keywords
- lotion composition
- absorbent article
- mass
- surfactant
- fatty acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 163
- 239000006210 lotion Substances 0.000 title claims abstract description 161
- 239000002250 absorbent Substances 0.000 title claims abstract description 85
- 230000002745 absorbent Effects 0.000 title claims abstract description 85
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 61
- 239000004094 surface-active agent Substances 0.000 claims abstract description 55
- -1 hydroxy fatty acid Chemical class 0.000 claims abstract description 52
- 239000000194 fatty acid Substances 0.000 claims abstract description 47
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 46
- 229930195729 fatty acid Natural products 0.000 claims abstract description 46
- 235000011187 glycerol Nutrition 0.000 claims abstract description 36
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims abstract description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 24
- 229930186217 Glycolipid Natural products 0.000 claims abstract description 8
- 150000002402 hexoses Chemical class 0.000 claims abstract description 8
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 8
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 claims abstract description 7
- 230000002209 hydrophobic effect Effects 0.000 claims description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000004615 ingredient Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 description 17
- 239000000284 extract Substances 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 15
- 150000004665 fatty acids Chemical class 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 239000003974 emollient agent Substances 0.000 description 8
- 229930003231 vitamin Natural products 0.000 description 8
- 239000011782 vitamin Substances 0.000 description 8
- 235000013343 vitamin Nutrition 0.000 description 8
- 229940088594 vitamin Drugs 0.000 description 8
- 230000003100 immobilizing effect Effects 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 5
- 238000006116 polymerization reaction Methods 0.000 description 5
- 235000015170 shellfish Nutrition 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 230000036760 body temperature Effects 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000004530 micro-emulsion Substances 0.000 description 4
- 229920000139 polyethylene terephthalate Polymers 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 150000004671 saturated fatty acids Chemical group 0.000 description 4
- 150000004670 unsaturated fatty acids Chemical group 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- UJEADPSEBDCWPS-SGJODSJKSA-N (2R,3R)-1-[(3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]butane-1,2,3,4-tetrol Chemical class C1([C@@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)C([C@H](O)[C@H](O)CO)O UJEADPSEBDCWPS-SGJODSJKSA-N 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical class C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 229930195733 hydrocarbon Natural products 0.000 description 3
- 150000002430 hydrocarbons Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000007908 nanoemulsion Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 229920000223 polyglycerol Polymers 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012209 synthetic fiber Substances 0.000 description 3
- 229920002994 synthetic fiber Polymers 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical group OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- 208000035484 Cellulite Diseases 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000555712 Forsythia Species 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 244000219416 Hypericum japonicum Species 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010049752 Peau d'orange Diseases 0.000 description 2
- 241001212699 Pinctada martensii Species 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000001153 anti-wrinkle effect Effects 0.000 description 2
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 2
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 108010006161 conchiolin Proteins 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 2
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 239000003208 petroleum Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 229960004063 propylene glycol Drugs 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- YAPQBXQYLJRXSA-UHFFFAOYSA-N theobromine Chemical compound CN1C(=O)NC(=O)C2=C1N=CN2C YAPQBXQYLJRXSA-UHFFFAOYSA-N 0.000 description 2
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 2
- 239000001430 tilia cordata extract Substances 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 239000007762 w/o emulsion Substances 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- WRGQSWVCFNIUNZ-GDCKJWNLSA-N 1-oleoyl-sn-glycerol 3-phosphate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)COP(O)(O)=O WRGQSWVCFNIUNZ-GDCKJWNLSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical class O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 240000005528 Arctium lappa Species 0.000 description 1
- 235000003130 Arctium lappa Nutrition 0.000 description 1
- 235000008078 Arctium minus Nutrition 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 235000002992 Betula pubescens Nutrition 0.000 description 1
- 241001520764 Betula pubescens Species 0.000 description 1
- 229920002799 BoPET Polymers 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 239000005632 Capric acid (CAS 334-48-5) Substances 0.000 description 1
- 241000218645 Cedrus Species 0.000 description 1
- 235000007866 Chamaemelum nobile Nutrition 0.000 description 1
- 241000272194 Ciconiiformes Species 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 240000007049 Juglans regia Species 0.000 description 1
- 235000009496 Juglans regia Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 108010028921 Lipopeptides Proteins 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000042664 Matricaria chamomilla Species 0.000 description 1
- 235000007232 Matricaria chamomilla Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000237536 Mytilus edulis Species 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 241000490567 Pinctada Species 0.000 description 1
- 241001490476 Pinctada maxima Species 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- JVWLUVNSQYXYBE-UHFFFAOYSA-N Ribitol Natural products OCC(C)C(O)C(O)CO JVWLUVNSQYXYBE-UHFFFAOYSA-N 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229910052908 analcime Inorganic materials 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 1
- OWBTYPJTUOEWEK-UHFFFAOYSA-N butane-2,3-diol Chemical compound CC(O)C(C)O OWBTYPJTUOEWEK-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- UNYSKUBLZGJSLV-UHFFFAOYSA-L calcium;1,3,5,2,4,6$l^{2}-trioxadisilaluminane 2,4-dioxide;dihydroxide;hexahydrate Chemical compound O.O.O.O.O.O.[OH-].[OH-].[Ca+2].O=[Si]1O[Al]O[Si](=O)O1.O=[Si]1O[Al]O[Si](=O)O1 UNYSKUBLZGJSLV-UHFFFAOYSA-L 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 230000036232 cellulite Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229910052676 chabazite Inorganic materials 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940107161 cholesterol Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical class O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000013505 freshwater Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229960004275 glycolic acid Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910052677 heulandite Inorganic materials 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229940106579 hops extract Drugs 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 239000001906 humulus lupulus l. absolute Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229910052680 mordenite Inorganic materials 0.000 description 1
- 235000020638 mussel Nutrition 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229910052674 natrolite Inorganic materials 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960004559 theobromine Drugs 0.000 description 1
- 229960000278 theophylline Drugs 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 150000005691 triesters Chemical class 0.000 description 1
- 125000005457 triglyceride group Chemical group 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011708 vitamin B3 Substances 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical group 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical group 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 235000020234 walnut Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Absorbent Articles And Supports Therefor (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
Abstract
The present invention relates to an absorbent article comprising a lotion composition and the lotion composition. Provided is an absorbent article provided with a lotion composition which is not easily moved before the absorbent article is used, is easily transferred to the skin of a wearer from the beginning of wearing, and easily protects the skin of the wearer. An absorbent article characterized in that a liquid-permeable sheet is provided with a lotion composition on its skin contact surface, the lotion composition comprising: (i) a glycolipid surfactant comprising 1 molecule of hexose to which 1 molecule of C is glycosidically bondednH2n+ 2On(n is an integer of 4 to 6) a molecule derived from a sugar alcohol and a hydroxy fatty acid; and (ii) hydrophobicityAnd (b) a component (a) containing at least 1 selected from the group consisting of a glycerin fatty acid ester, a polyglycerin fatty acid ester, a propylene oxide and/or butylene oxide adduct of glycerin, and a propylene oxide and/or butylene oxide adduct of polyglycerin.
Description
Technical Field
The present application relates to absorbent articles comprising a lotion composition and the lotion composition.
Background
Absorbent articles provided with a lotion composition are known.
For example, patent document 1 discloses a lotion composition for the purpose of suppressing the adhesion of excrement to the skin of a wearer, and an absorbent article provided with the lotion composition. The lotion composition described in patent document 1 has the following structure.
A lotion composition characterized by being a lotion composition which is applied to an absorbent article worn by a wearer and which is semi-solid or solid at 20 ℃, said lotion composition comprising: (A) 20-95 wt% of an emollient having a plastic or fluid consistency at 20 ℃, comprising less than 5 wt% moisture relative to the total amount of the emollient, the emollient comprising one selected from the group consisting of petroleum based emollients, alkyl ethoxylate emollients and mixtures thereof, said petroleum comprising a hydrocarbon or mixture of hydrocarbons having a chain length of 16-32 carbon atoms; and (B)5 to 80 wt% of an immobilizing agent capable of immobilizing an emollient on the surface of a topsheet of an absorbent article treated with the lotion composition, the immobilizing agent having a melting point of 50 to 150 ℃ and comprising a component selected from the group consisting of C14-C22Fatty alcohols and C12-C22One of the fatty acids.
In addition, it has been studied to suppress irritation to the skin by coating synthetic fibers with a fiber treatment agent. For example, patent document 2 discloses that hydrophilic synthetic fibers are obtained by attaching a fiber treatment agent to the surface of synthetic fibers, the fiber treatment agent comprising: (a) a surfactant which is at least 1 selected from the group consisting of surfactants having a lipopeptide structure represented by surface active peptides (surfactants), and surfactants of glycolipids represented by sophorolipids, rhamnolipids, and mannosylerythritol lipids; (b) at least 1 compound selected from the group consisting of (poly) glycerol, (poly) glycerol fatty acid ester and alkylene oxide adduct of (poly) glycerol; and (c) a lactate, wherein the component (a) is contained in an amount of 2.5 to 50 mass% based on 100 mass% of the total mass of the components (a) to (c).
Documents of the prior art
Patent document
Patent document 1: japanese laid-open patent publication No. 2009 and 137964
Patent document 2: japanese patent laid-open No. 2012 and 57275
Disclosure of Invention
Problems to be solved by the invention
In order to suppress permeation of the lotion composition into the interior of the absorbent article, the lotion composition described in patent document 1 contains an immobilizing agent capable of immobilizing an emollient having a plastic or fluid consistency at 20 ℃.
Therefore, the lotion composition described in patent document 1 is difficult to transfer to the skin of the wearer before the immobilizing agent in the lotion composition melts at the beginning of wearing of the absorbent article, and difficult to protect the skin of the wearer at the beginning of wearing of the absorbent article.
Further, the fiber treatment agent described in patent document 2 does not transfer to the skin of the wearer.
Accordingly, an object of the present invention is to provide an absorbent article provided with a lotion composition which is less likely to move before the absorbent article is used, and which is easily transferred from the beginning of wearing to the skin of a wearer, thereby easily protecting the skin of the wearer.
Means for solving the problems
The present applicant has found an absorbent article comprising a liquid-permeable sheet, a liquid-impermeable sheet, and an absorbent body therebetween, wherein the liquid-permeable sheet has a skin contact surface and a non-skin contact surface, and the liquid-permeable sheet has a lotion composition on the skin contact surface, the lotion composition comprising: (i) a glycolipid surfactant comprising 1 molecule of hexose to which 1 molecule of C is glycosidically bondednH2n+2On(n is an integer of 4 to 6) a molecule derived from a sugar alcohol and a hydroxy fatty acid; and (ii) a hydrophobic component comprising propylene oxide and/or butylene oxide addition selected from the group consisting of glycerol fatty acid esters, polyglycerol fatty acid esters, and glycerolAnd a propylene oxide and/or butylene oxide adduct of polyglycerin.
ADVANTAGEOUS EFFECTS OF INVENTION
The lotion composition in the absorbent article of the present application is not easily moved before the absorbent article is used and easily transferred to the skin of the wearer from the beginning of wearing, and easily protects the skin of the wearer.
Drawings
Fig. 1 is a graph for explaining the results of example 1 and comparative examples 1 and 2.
Detailed Description
Specifically, the present application relates to the following embodiments.
[ means 1]
An absorbent article comprising a liquid-permeable sheet, a liquid-impermeable sheet and an absorbent body therebetween, wherein the liquid-permeable sheet has a skin contact surface and a non-skin contact surface,
the liquid-permeable sheet is provided with a lotion composition on the skin contact surface, the lotion composition comprising:
(i) a glycolipid surfactant comprising 1 molecule of hexose to which 1 molecule of C is glycosidically bondednH2n+2On(n is an integer of 4 to 6) a molecule derived from a sugar alcohol and a hydroxy fatty acid; and
(ii) a hydrophobic component containing at least 1 selected from the group consisting of glycerin fatty acid ester, polyglycerin fatty acid ester, propylene oxide and/or butylene oxide adduct of glycerin, and propylene oxide and/or butylene oxide adduct of polyglycerin.
The absorbent article is provided with a lotion composition on the skin-contacting surface of the liquid-permeable sheet, the lotion composition containing a predetermined (i) surfactant and a predetermined (ii) hydrophobic component. Therefore, the lotion composition can have a predetermined viscosity at room temperature (25 ℃), and the lotion composition is less likely to migrate into the absorbent article before the absorbent article is used.
Further, the lotion composition can have a predetermined viscosity at room temperature (25 ℃), and the lotion composition can be easily transferred to the skin of the wearer even before the lotion composition is warmed by the body temperature of the wearer at the beginning of wearing the absorbent article.
Further, the above lotion composition contains (i) a surfactant, and therefore (i) a surfactant can protect the skin of a wearer.
Further, since the lotion composition contains (i) a surfactant and (ii) a hydrophobic component, the lotion composition can retain other components having properties such as water solubility, hydrophilicity, hydrophobicity (lipophilicity), and oil solubility. For example, the lotion composition can be held in the (ii) hydrophobic component by dissolving the other component having oil solubility, and can be held in the (ii) hydrophobic component by micellizing the other component having hydrophobicity (lipophilicity), water solubility or hydrophilicity with the (i) surfactant as necessary.
As described above, in the absorbent article, the lotion composition is not easily moved before the absorbent article is used, and is easily transferred to the skin of the wearer from the beginning of wearing, and the skin of the wearer is easily protected.
[ means 2]
The absorbent article according to mode 1, wherein the lotion composition contains the (i) surfactant and the (ii) hydrophobic component at a ratio of 1.0 to 22.0% by mass and 78.0 to 99.0% by mass, respectively, with respect to 100% by mass of the total of the (i) surfactant and the (ii) hydrophobic component.
In the absorbent article, since the lotion composition contains (i) the surfactant and (ii) the hydrophobic component at a predetermined mass ratio, the lotion composition is less likely to move before the absorbent article is used, is likely to transfer from the beginning of wearing to the skin of the wearer, and is likely to protect the skin of the wearer.
[ means 3]
The absorbent article according to mode 1 or 2, wherein the lotion composition further comprises (iii) an aqueous hydrophilic component.
In the absorbent article, since the lotion composition contains the predetermined hydrophilic component (iii), the viscosity of the lotion composition can be easily adjusted to a predetermined range.
In the absorbent article, the lotion composition contains the predetermined hydrophilic component (iii), and therefore, the other component having water solubility can be held in the hydrophilic component (iii) by dissolving the other component having water solubility, and the other component having hydrophilicity can be held in the hydrophilic component (iii) by micellizing the other component having hydrophilicity with the surfactant (i) as necessary. As a result, the lotion composition can easily transfer other components having water solubility or hydrophilicity to the skin of the wearer quickly after contacting the skin of the wearer.
[ means 4]
The absorbent article according to any one of aspects 1 to 3, wherein the lotion composition contains the surfactant (i), the hydrophobic component (ii), and the hydrophilic component (iii) at a ratio of 1.0 to 20.0 mass%, 78.0 to 98.9 mass%, and 0.1 to 2.0 mass%, respectively, with respect to 100 mass% of the total of the surfactant (i), the hydrophobic component (ii), and the hydrophilic component (iii).
In the absorbent article, since the lotion composition contains (i) the surfactant, (ii) the hydrophobic component and (iii) the hydrophilic component at a predetermined mass ratio, the lotion composition is less likely to move before the absorbent article is used, is easily transferred from the beginning of wearing to the skin of the wearer, and is likely to protect the skin of the wearer.
[ means 5]
The absorbent article according to any one of aspects 1 to 4, wherein the lotion composition has a viscosity of 15 to 40 mPas at 25 ℃.
In the absorbent article, the lotion composition has a predetermined viscosity at room temperature (25 ℃), and therefore, the lotion composition is not easily moved before the absorbent article is used and is easily transferred from the beginning of wearing to the skin of the wearer.
[ means 6]
The absorbent article according to any one of aspects 1 to 5, wherein the lotion composition has a viscosity of 15 to 30 mPas at 36 ℃.
In the absorbent article, the lotion composition has a predetermined viscosity at 36 ℃, and therefore, even when the lotion composition is warmed by the body temperature of the wearer after moving to the skin of the wearer, the lotion composition is less likely to move from the skin of the wearer to other parts, for example, the inside of the absorbent article.
[ means 7]
The absorbent article according to any one of aspects 1 to 6, wherein the difference between the viscosity at 36 ℃ and the viscosity at 25 ℃ of the lotion composition is 6 mPas or less.
In the absorbent article, since the difference between the viscosity at 36 ℃ and the viscosity at 25 ℃ of the lotion composition is within a predetermined range, the lotion composition easily exhibits uniform performance from the beginning of wearing to wearing, and also exhibits the same performance in environments with different temperatures (e.g., late morning in low latitudes and late winter in high latitudes).
[ means 8]
The absorbent article according to any one of aspects 1 to 7, wherein the surfactant (i) is a mannosylerythritol lipid.
In the above absorbent article, the surfactant (i) is a mannosylerythritol lipid, and therefore, the effect of protecting the skin of the wearer is high. The role of mannosylerythritol lipids is well known, and therefore, the description of the present specification is omitted.
[ means 9]
The absorbent article according to any one of aspects 1 to 8, wherein the (ii) hydrophobic component is a glycerin fatty acid triester.
In the absorbent article, since (ii) the hydrophobic component is triglyceride, the lotion composition can stably exist due to a surface active effect derived from triglyceride, and can exert a moisturizing effect derived from triglyceride.
[ means 10]
The absorbent article according to mode 3, wherein the (iii) hydrophilic component further comprises an alcohol.
In the above-mentioned absorbent article, the (iii) hydrophilic component further contains an alcohol, and therefore, the lotion composition can stably retain the other components (for example, components derived from pearl) dissolved in the alcohol, and the other components dissolved in the alcohol are easily transferred to the skin of the wearer quickly after the lotion composition contacts the skin of the wearer.
[ means 11]
The absorbent article according to any one of aspects 1 to 10, wherein the mass per unit area of the lotion composition disposed on the skin contact surface is larger than the mass per unit area of the lotion composition disposed on the non-skin contact surface.
In the absorbent article described above, the mass per unit area of the lotion composition disposed on the skin contact surface is larger than the mass per unit area of the lotion composition disposed on the non-skin contact surface, and therefore, when the skin of the wearer contacts the skin contact surface of the liquid-permeable sheet of the absorbent article, the lotion composition is more easily transferred to the skin of the wearer.
[ means 12]
A lotion composition for an absorbent article,
the lotion composition comprises:
(i) a glycolipid surfactant comprising 1 molecule of hexose to which 1 molecule of C is glycosidically bondednH2n+2On(n is an integer of 4 to 6) a molecule derived from a sugar alcohol and a hydroxy fatty acid; and
(ii) a hydrophobic component containing at least 1 selected from the group consisting of glycerin fatty acid ester, polyglycerin fatty acid ester, propylene oxide and/or butylene oxide adduct of glycerin, and propylene oxide and/or butylene oxide adduct of polyglycerin.
The above lotion composition has the same effect as in mode 1.
[ means 13]
The lotion composition according to mode 12, wherein the lotion composition comprises the (i) surfactant and the (ii) hydrophobic component at a ratio of 1.0 to 22.0% by mass and 78.0 to 99.0% by mass, respectively, relative to 100% by mass of the total of the (i) surfactant and the (ii) hydrophobic component.
The above lotion composition has the same effect as in mode 2.
[ means 14]
The lotion composition according to mode 12 or 13, wherein the lotion composition further comprises (iii) an aqueous hydrophilic component.
The above lotion composition has the same effect as in mode 3.
[ means 15]
The lotion composition according to any one of aspects 12 to 14, wherein the lotion composition comprises the surfactant (i), the hydrophobic component (ii), and the hydrophilic component (iii) at a ratio of 1.0 to 20.0 mass%, 78.0 to 98.9 mass%, and 0.1 to 2.0 mass%, respectively, relative to 100 mass% of the total of the surfactant (i), the hydrophobic component (ii), and the hydrophilic component (iii).
The above lotion composition has the same effect as in mode 4.
The absorbent article and the lotion composition containing the lotion composition of the present application are described in detail below.
The absorbent article of the present application includes a liquid-permeable sheet having a skin contact surface and a non-skin contact surface, a liquid-impermeable sheet, and an absorbent body therebetween.
The liquid-permeable sheet contains a predetermined lotion composition on the skin contact surface.
[ lotion composition ]
In the absorbent article of the present application, the lotion composition contains the following components.
(i) A glycolipid surfactant comprising 1 molecule of hexose to which 1 molecule of C is glycosidically bondednH2n+2OnA molecule obtained from a sugar alcohol (n is an integer of 4 to 6) and a hydroxy fatty acid (hereinafter, sometimes referred to as a "surfactant");
(ii) a hydrophobic component containing at least 1 selected from the group consisting of a glycerin fatty acid ester, a polyglycerin fatty acid ester, a propylene oxide and/or butylene oxide adduct of glycerin, and a propylene oxide and/or butylene oxide adduct of polyglycerin (hereinafter sometimes referred to as "hydrophobic component").
The lotion composition may further contain the following components.
(iii) A hydrophilic component containing water (hereinafter sometimes referred to as "(iii) hydrophilic component").
[ (i) surfactant ]
Examples of the surfactant (i) include Mannitol Ester (MEL), mannose mannitol ester (MML), mannose sorbitol ester (MSL), mannose arabitol ester (MAraL), and mannose ribitol ester (MRL), and MEL is preferable.
MEL is a molecule in which mannose 1 molecules, which are 1 kind of hexose, and erythritol 1 molecules, which are 1 kind of sugar alcohol, are bonded to each other via a glycosidic bond, and has a structure in which a hydroxy fatty acid and an acetyl group are introduced into a hydroxyl group of a mannose-derived part.
MEL has the following formula (1).
In the formula, R1～R4Each independently hydrogen (-H), acetyl (-COCH)3) Or preferably C1～C36More preferably C3～C12A saturated fatty acid residue or an unsaturated fatty acid residue. R1～R4At least 1 of them being acetyl, the other at least 1 being C1～C36A saturated fatty acid residue or an unsaturated fatty acid residue.
R1And R2Are each independently preferably C1～C25More preferably C3～C25More preferably C5～C14And, more preferably C8～C12A saturated fatty acid residue or an unsaturated fatty acid residue. R3And R4Both may be acetyl groups, and further, one may be an acetyl group and the other may be a hydrogen atom.
In the present specification, mannosylerythritol lipids (MEL) is a generic term including MEL itself, its congeners and salts thereof.
MEL is typically produced by microorganisms. A method of manufacturing MEL is well known, and thus, a description thereof is omitted.
[ (ii) hydrophobic component ]
(ii) The hydrophobic component is a hydrophobic component containing at least 1 selected from the group consisting of glycerin fatty acid ester, polyglycerin fatty acid ester, propylene oxide and/or butylene oxide adduct of glycerin, and propylene oxide and/or butylene oxide adduct of polyglycerin.
The glycerol fatty acid ester is monoester, diester or triester of monoglyceride and fatty acid, and comprises glycerol fatty acid monoester, glycerol fatty acid diester and glycerol fatty acid triester. The glycerin fatty acid ester is preferably a glycerin fatty acid diester or a glycerin fatty acid triester, and more preferably a glycerin fatty acid triester. This is because the hydrophobic component (ii) is hydrophobic.
The fatty acid is preferably C10～C22Fatty acid, and more preferably C12～C18A fatty acid. The fatty acids may be saturated or unsaturated. Specific examples of the fatty acid include capric acid, lauric acid, tridecanoic acid, myristic acid, pentadecanoic acid, palmitic acid, margaric acid, stearic acid, isostearic acid, nonadecanoic acid, arachidic acid, behenic acid (the above is a saturated fatty acid), and oleic acid (the above is an unsaturated fatty acid).
The polyglycerin fatty acid ester is preferably obtained by ester-bonding a polyglycerin having an average polymerization degree of 2 to 15 with a fatty acid. The fatty acids are as described above.
In the present specification, the average polymerization degree of polyglycerol means the polymerization degree calculated from the hydroxyl value thereof.
The polyglycerin fatty acid ester is one in which an ester bond is formed with a fatty acid preferably at 40 mol% or more, more preferably at 60 mol% or more, and further preferably at 80 mol% or more of the hydroxyl groups of the polyglycerin. This is because the hydrophobic component (ii) is hydrophobic.
In the propylene oxide and/or butylene oxide adduct of glycerin, the average molar number of addition of propylene oxide and/or butylene oxide is preferably 2 to 30, more preferably 4 to 24, and further preferably 8 to 20.
The propylene oxide and/or butylene oxide adduct of glycerin is a concept including a propylene oxide adduct of glycerin, a butylene oxide adduct of glycerin, and a propylene oxide and butylene oxide adduct of glycerin.
Among the propylene oxide and/or butylene oxide adducts of the polyglycerin, the polyglycerin is preferably a polyglycerin having an average polymerization degree of 2 to 30, and more preferably 2 to 15. Preferably as described above.
In the adduct of propylene oxide and/or butylene oxide of polyglycerol, the average molar number of addition of propylene oxide and/or butylene oxide is preferably 2 to 30, more preferably 4 to 24, and still more preferably 8 to 20.
[ (iii) hydrophilic component ]
The hydrophilic component (iii) of the lotion composition contains water according to the desired ingredients. As the water, for example, deionized water can be cited. (iii) The hydrophilic component may consist of water only.
In addition, (iii) the hydrophilic component may comprise a water-miscible organic solvent.
Examples of the water-soluble organic solvent include alcohols (e.g., methanol, ethanol, propanol, butanol), glycols (e.g., ethylene glycol, propylene glycol, e.g., 1, 2-propylene glycol, 1, 3-propylene glycol, butylene glycol, e.g., 1, 3-butylene glycol, 1, 4-butylene glycol, 2, 3-butylene glycol), glycerin, polyglycerin, ethylene oxide adducts of glycerin or polyglycerin, ketones (e.g., acetone, methyl ethyl ketone), and the like, and alcohols are preferable, and ethanol is particularly preferable.
The lotion composition can contain the above-mentioned water-soluble organic solvent in a range miscible with water at body temperature (36 ℃), a range miscible with water at room temperature (25 ℃), and the like, for example, when the absorbent article is worn.
The polyglycerin is preferably a polyglycerin having an average polymerization degree of 2 to 30, and more preferably 2 to 15. Specific examples of the polyglycerin include diglycerin, tetraglycerin, hexaglycerin, octaglycerin, decaglycerin, and the like.
In the ethylene oxide adduct of glycerin or polyglycerin, the average molar number of addition of ethylene oxide is preferably 2 to 30, more preferably 4 to 24, and further preferably 8 to 20.
The lotion composition may be an oil-in-water or water-in-oil emulsion (e.g., microemulsion, nanoemulsion, etc.) in which (ii) a hydrophobic component or (iii) a hydrophilic component is retained in (iii) a hydrophilic component or (ii) a hydrophobic component, which is micellized with (i) a surfactant. The lotion composition is preferably a water-in-oil emulsion (e.g., microemulsion, nanoemulsion, etc.) in which (iii) a hydrophilic component micellized with (i) a surfactant is retained in (ii) a hydrophobic component. Thus, the (i) surfactant, (ii) hydrophobic component, and (iii) hydrophilic component can act on the skin of the wearer as needed, and the lotion composition can easily maintain a desired viscosity and can easily exert its function.
In the above lotion composition, the (i) surfactant and the (ii) hydrophobic component are contained preferably in a ratio of 1.0 to 22.0% by mass and 78.0 to 99.0% by mass, more preferably in a ratio of 3.0 to 18.7% by mass and 81.3 to 97.0% by mass, respectively, and further preferably in a ratio of 5.0 to 16.5% by mass and 83.5 to 95.0% by mass, respectively, relative to 100% by mass of the total of the (i) surfactant and the (ii) hydrophobic component. As a result, the lotion composition is less likely to move before the absorbent article is used, is easily transferred from the beginning of wearing to the skin of the wearer, and is thus likely to protect the skin of the wearer.
When the lotion composition further contains (iii) a hydrophilic component, the lotion composition preferably contains (i) a surfactant, (ii) a hydrophobic component and (iii) a hydrophilic component in a ratio of 1.0 to 20.0 mass%, 78.0 to 98.9 mass% and 0.1 to 2.0 mass%, more preferably 3.0 to 17.0 mass%, 81.3 to 96.7 mass% and 0.3 to 1.7 mass%, respectively, and further preferably contains (i) a surfactant, (ii) a hydrophobic component and (iii) a hydrophilic component in a ratio of 5.0 to 15.0 mass%, 83.5 to 94.5 mass% and 0.5 to 1.5 mass%, respectively, relative to 100 mass% of the total of (i) a surfactant, (ii) a hydrophobic component and (iii) a hydrophilic component. As a result, the lotion composition is likely to form an emulsion (e.g., a microemulsion, a nanoemulsion, etc.), and the lotion composition tends to maintain a desired viscosity, and as a result, is less likely to move before the absorbent article is used, is likely to transfer to the skin of the wearer from the beginning of wearing, and is likely to protect the skin of the wearer.
The lotion composition has a viscosity of preferably 15 to 40 mPas, more preferably 16 to 35 mPas, and still more preferably 17 to 30 mPas at room temperature (25 ℃). Thus, the lotion composition is not easily moved before the absorbent article is used and is easily transferred to the wearer's skin from the beginning of wearing.
The lotion composition has a viscosity of preferably 15 to 30 mPas, more preferably 16 to 27 mPas, and further preferably 17 to 25 mPas at 36 ℃. Thus, the lotion composition is less likely to move from the skin of the wearer to other parts, for example, the inside of the absorbent article, even when warmed by the body temperature of the wearer after moving to the skin of the wearer.
The difference between the viscosity at 36 ℃ and the viscosity at 25 ℃ of the lotion composition is preferably 6 mPas or less, preferably 5 mPas or less, and more preferably 4 mPas or less. Thus, the lotion composition can easily exhibit uniform performance from the start of wearing to the time of wearing, and can exhibit the same performance even in environments of different temperatures (for example, daytime in low latitudes and winter in high latitudes).
In the present specification, the viscosity of the lotion composition can be measured using the following apparatus.
Equipment: manufactured by Thermo Fisher SCIENTIFIC
HAAKE RheoStress1
The sensor: cone phi 60mm, 1 degree angle C60/1
Shear rate: 100.0(1/s)
Measurement time: 30 seconds
Sampling: 100, calculating an average value
[ other ingredients ]
The lotion composition of the present application may contain other ingredients within the range exerting its effect.
As the other components, pearl-derived components can be mentioned.
The pearl-derived component is not particularly limited as long as it is derived from a shellfish having a pearl layer. Examples of the shellfish having a pearl layer include marine shellfish such as pinctada martensii, pinctada martensii (black pearl), pinctada maxima (south American pearl), penguin pearl oyster (horse pearl), abalone, mussel (freshwater pearl), and the like.
The pearl-derived component may be a pulverized product, i.e., a powder, of the shellfish having a pearl layer, and may be an organic substance of the shellfish having a pearl layer, for example, a protein conchiolin, a peptide derived from the organic substance, an amino acid, for example, a hydrolyzed conchiolin, and the like. The above-mentioned peptide, amino acid and the like may be in a liquid state.
Examples of the other components include a perfume and a solvent.
Examples of the other component include silicone oil, silicone resin, and the like.
Examples of the other components include antioxidants such as BHT (2, 6-di-tert-butyl-p-cresol), BHA (butylated hydroxyanisole), and propyl gallate.
Examples of the other components include vitamins, such as natural vitamins and synthetic vitamins. Examples of the vitamins include water-soluble vitamins, e.g., vitamin B group, e.g., vitamin B1Vitamin B2Vitamin B3Vitamin B5Vitamin B6Vitamin B7Vitamin B9Vitamin B12Etc., vitamin C.
Examples of the vitamins include fat-soluble vitamins, such as vitamin a group, vitamin D group, vitamin E group, and vitamin K group.
In addition, the vitamins mentioned above also include their derivatives.
Examples of the other components include amino acids such as alanine, arginine, lysine, histidine, proline, hydroxyproline, and peptides.
Examples of the other components include zeolites such as natural zeolites, for example, analcime, chabazite, heulandite, natrolite, mordenite, and thomosonite (thomosonite), and synthetic zeolites.
Examples of the other components include cholesterol, hyaluronic acid, lecithin, and ceramide.
Examples of the other components include a drug, such as a skin astringent, an anti-pimple agent, an anti-wrinkle agent, an anti-cellulite agent, a whitening agent, an antibacterial agent, and an antifungal agent.
Examples of the skin astringent include zinc oxide, aluminum sulfate, tannic acid, and the like, oil-soluble skin astringent, and oil-soluble polyphenol. Examples of the oil-soluble polyphenol include natural oil-soluble polyphenols such as phellodendron extract, forsythia extract, sesamum indicum extract, chamomile extract, burdock extract, hypericum japonicum extract, linden extract, betula alba extract, cedar extract, sage extract, hypericum japonicum extract, walnut extract, hibiscus extract, loquat leaf extract, linden extract, hops extract, horse chestnut extract, and coix seed extract.
Examples of the anti-pimple agent include salicylic acid, benzoyl peroxide, resorcinol, sulfur, erythromycin, zinc, and the like.
Examples of the anti-wrinkle agent include lactic acid, salicylic acid derivatives, glycolic acid, phytic acid, lipoic acid, and lysophosphatidic acid.
Examples of the anti-subcutaneous cellulite agent include xanthine compounds, such as aminophylline, caffeine, theophylline, and theobromine.
Examples of the whitening agent include niacinamide, kojic acid, arbutin, glucosamine and derivatives thereof, phytosterol derivatives, ascorbic acid and derivatives thereof, and mulberry extract and placenta extract.
Examples of the other components include anti-inflammatory components, pH regulators, antibacterial agents, moisturizers, perfumes, colorants, dyes, pigments, plant extracts, and the like. Examples of the anti-inflammatory component include natural anti-inflammatory agents such as peony, scutellaria, forsythia, chamomile, licorice, peach leaf, mugwort, and perilla extract, synthetic anti-inflammatory agents such as allantoin and dipotassium glycyrrhizinate.
Examples of the pH adjuster include substances for keeping skin weakly acidic, such as malic acid, succinic acid, citric acid, tartaric acid, and lactic acid.
Examples of the pigment include titanium oxide.
The other components may have water-soluble, hydrophilic, hydrophobic (lipophilic), and oil-soluble properties.
In the absorbent article of the present application, the lotion composition contains at least three components of (i) a surfactant, (ii) a hydrophobic component, and (iii) a hydrophilic component, and therefore, the other components can be appropriately retained.
Specifically, the lotion composition can retain other components having water solubility in the (iii) hydrophilic component by, for example, dissolution, or (ii) hydrophobic component by micellization with (i) a surfactant.
In addition, the above-mentioned lotion composition can be retained in the (iii) hydrophilic component and the (ii) hydrophobic component, respectively, by micellizing the other hydrophilic and hydrophobic components with the (i) surfactant.
Further, the lotion composition may have other components having oil solubility held in (ii) the hydrophobic component by, for example, dissolution or (iii) the hydrophilic component by micellization with (i) the surfactant.
It is noted that (iii) the hydrophilic component is an optional component of the lotion composition.
In the absorbent article of the present application, the liquid-permeable sheet is provided with a lotion composition on the skin contact surface thereof. The lotion composition may be disposed on the skin contact surface of the liquid-permeable sheet without particular limitation. For example, the plurality of line-like lotion compositions may be disposed so as to be spaced apart in the width direction of the absorbent article and extend along the longitudinal direction of the absorbent article. Further, a plurality of spot-like lotion compositions may be arranged in a zigzag shape on the skin contact surface of the liquid-permeable sheet.
The absorbent article of the present application may preferably be in the range of 3.0 to 8.0g/m2And more preferably 4.0 to 6.0g/m2Has the above lotion composition per unit mass.
In the absorbent article of the present application, the mass per unit area of the lotion composition disposed on the skin contact surface of the liquid-permeable sheet is preferably larger than the mass per unit area of the lotion composition disposed on the non-skin contact surface of the liquid-permeable sheet. Thus, when the skin of the wearer contacts the skin-contacting surface of the liquid-permeable sheet of the absorbent article, the lotion composition is more easily transferred to the skin of the wearer.
The absorbent article of the present application is not particularly limited as long as it is in contact with the skin of the wearer, and examples thereof include disposable diapers, incontinence pads, disposable pants, sanitary napkins, panty liners, pet diapers, and pet sheets.
Examples
The present application will be described below by way of examples, but the present application is not limited to these examples.
Production example 1
Lotion composition No.1 was prepared by mixing 10 parts by mass of MEL (CERAMERA-HG, manufactured by Toyo Co., Ltd.) as a surfactant (i), 89 parts by mass of glyceryl tri (caprylic/capric) ester (manufactured by Nichikoku Co., Ltd., Panasate (trademark) 810S) as a hydrophobic component (ii), and 1 part by mass of deionized water as a hydrophilic component (iii) at 40 ℃. When lotion composition No.1 was left to stand at room temperature (25 ℃ C.) for 24 hours, lotion composition No.1 had a transparent property. This is considered to be because lotion composition No.1 formed a water-in-oil microemulsion.
When the viscosity of lotion composition No.1 was measured by the method described in the present specification, lotion composition No.1 had a viscosity of 22 mPas at 36 ℃ and a viscosity of 19 mPas at 25 ℃.
Washing composition No.1 was added at 5.0g/m2The mass per unit area of (A) was applied to a PET release film (PET 38X 1-B, 100mm X100 mm, manufactured by NIPPA corporation) to prepare a plurality of samples of lotion composition-coated film No. 1.
Production example 2
Lotion composition No.2 was prepared by mixing 10 parts by mass of MEL (CERAMERA-HG, manufactured by Toyo Co., Ltd.) as (i) a surfactant, 89 parts by mass of glyceryl tri (caprylic/capric acid) (manufactured by Nichikoku Co., Ltd., Panasate (trademark) 810S) as (ii) a hydrophobic component, 0.7 part by mass of deionized water as (iii) a hydrophilic component, and 0.3 part by mass of ethanol at 40 ℃. When lotion composition No.2 was left to stand at room temperature (25 ℃ C.) for 24 hours, lotion composition No.2 had a transparent property.
Comparative production example 1
A lotion composition No.3 was produced by the method described in the specification of Japanese patent application laid-open No. Hei 10-509896. Specifically, 65 parts by mass of a hydrocarbon (PARLEAM 6, manufactured by Nichikoku corporation) as an emollient and 35 parts by mass of stearyl alcohol (a product obtained by adjusting NAA (trademark) -45, manufactured by Nichikoku corporation) as an inerting agent were mixed while heating to about 80 ℃ to prepare lotion composition No. 3.
The heated and liquefied lotion composition No.3 was set at 40g/m2And 10g/m2The film was coated on a PET release film (PET 38X 1-B, 100mm X100 mm, manufactured by NIPPA corporation) to prepare a plurality of samples of each of lotion composition-coated films No.2 and No. 3.
Example 1 and comparative examples 1 and 2
Artificial skin (PBZ 13001, 50 mm. times.50 mm, manufactured by IDEATEX JAPAN Co.) heated to 40 ℃ was placed on each of the lotion composition-coated films Nos. 1 to 3 in a thermostatic chamber at 25 ℃ and applied at 35gf/cm on the entire surface of the artificial skin2Loading weight under pressure for time and direction of lotion compositionThe relationship of the amount of transfer of the PET film was followed.
Specifically, the mass per unit area when the lotion composition is applied to the artificial skin is represented as BW0(g/m2) The initial mass of the artificial skin is recorded as m0(g) The mass of the artificial skin after t hours from the placement of the weight was recorded as mt(g) Then, the transfer rate of the lotion composition after t hours was calculated by the following formula: TR (transmitter-receiver)t(％)：
TRt(％)＝100×400×(mt-m0)/BW0
The results are shown in FIG. 1.
The lotion composition-coated films No.1 to No.3 had different transfer rates TR with the passage of timetThe value of (%) is a value measured using each sample.
According to FIG. 1, lotion composition No.1 exhibited a certain transferability from the beginning, i.e., from the time the temperature of lotion composition No.1 rose to 40 ℃, and also exhibited a certain transferability even when the temperature exceeded 40 ℃.
On the other hand, lotion compositions No.2 and No.3 tend to be as follows: the initial transfer rate is low, i.e., the transfer rate of the lotion composition is low until the temperature rises.
Claims (15)
1. An absorbent article comprising a liquid-permeable sheet, a liquid-impermeable sheet and an absorbent body therebetween, wherein the liquid-permeable sheet has a skin contact surface and a non-skin contact surface,
the liquid-permeable sheet is provided with a lotion composition on the skin contact surface, the lotion composition comprising:
(i) a glycolipid surfactant comprising 1 molecule of hexose to which 1 molecule of C is glycosidically bondednH2n+2OnA molecule obtained from the sugar alcohol of (1) and a hydroxy fatty acid, wherein n is an integer of 4 to 6; and
(ii) a hydrophobic component containing at least 1 selected from the group consisting of glycerin fatty acid ester, polyglycerin fatty acid ester, propylene oxide and/or butylene oxide adduct of glycerin, and propylene oxide and/or butylene oxide adduct of polyglycerin.
2. The absorbent article according to claim 1, wherein the lotion composition comprises (i) the surfactant and (ii) the hydrophobic component at a ratio of 1.0 to 22.0% by mass and 78.0 to 99.0% by mass, respectively, with respect to 100% by mass of the total of (i) the surfactant and (ii) the hydrophobic component.
3. The absorbent article of claim 1, wherein the lotion composition further comprises (iii) an aqueous hydrophilic component.
4. The absorbent article according to any one of claims 1 to 3, wherein the lotion composition contains (i) the surfactant, (ii) the hydrophobic component and (iii) the hydrophilic component at a ratio of 1.0 to 20.0 mass%, 78.0 to 98.9 mass% and 0.1 to 2.0 mass%, respectively, with respect to 100 mass% of the total of (i) the surfactant, (ii) the hydrophobic component and (iii) the hydrophilic component.
5. The absorbent article according to any one of claims 1 to 3, wherein the lotion composition has a viscosity of 15 to 40 mPa-s at 25 ℃.
6. The absorbent article according to any one of claims 1 to 3, wherein the lotion composition has a viscosity of 15 to 30 mPa-s at 36 ℃.
7. The absorbent article according to any one of claims 1 to 3, wherein the difference between the viscosity at 36 ℃ and the viscosity at 25 ℃ of the lotion composition is 6 mPas or less.
8. The absorbent article according to any one of claims 1 to 3, wherein the (i) surfactant is a mannosylerythritol lipid.
9. An absorbent article according to any one of claims 1 to 3, wherein the (ii) hydrophobic component is a glycerin fatty acid triester.
10. The absorbent article of claim 3, wherein (iii) the hydrophilic component further comprises an alcohol.
11. The absorbent article according to any one of claims 1 to 3, wherein the mass per unit area of the lotion composition disposed on the skin contact surface is larger than the mass per unit area of the lotion composition disposed on the non-skin contact surface.
12. A lotion composition for an absorbent article, the lotion composition comprising:
(i) a glycolipid surfactant comprising 1 molecule of hexose to which 1 molecule of C is glycosidically bondednH2n+2OnA molecule obtained from the sugar alcohol of (1) and a hydroxy fatty acid, wherein n is an integer of 4 to 6; and
(ii) a hydrophobic component containing at least 1 selected from the group consisting of glycerin fatty acid ester, polyglycerin fatty acid ester, propylene oxide and/or butylene oxide adduct of glycerin, and propylene oxide and/or butylene oxide adduct of polyglycerin.
13. The lotion composition according to claim 12, wherein the lotion composition comprises (i) the surfactant and (ii) the hydrophobic ingredient at a ratio of 1.0 to 22.0% by mass and 78.0 to 99.0% by mass, respectively, relative to 100% by mass of the total of (i) the surfactant and (ii) the hydrophobic ingredient.
14. The lotion composition of claim 12, wherein the lotion composition further comprises (iii) an aqueous hydrophilic component.
15. The lotion composition according to any one of claims 12 to 14, wherein the lotion composition comprises (i) the surfactant, (ii) the hydrophobic component and (iii) the hydrophilic component at a ratio of 1.0 to 20.0 mass%, 78.0 to 98.9 mass% and 0.1 to 2.0 mass%, respectively, relative to 100 mass% of the total of (i) the surfactant, (ii) the hydrophobic component and (iii) the hydrophilic component.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019217370A JP7233356B2 (en) | 2019-11-29 | 2019-11-29 | Absorbent article containing lotion composition, and lotion composition |
| JP2019-217370 | 2019-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112870426A true CN112870426A (en) | 2021-06-01 |
Family
ID=76043107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011358216.7A Pending CN112870426A (en) | 2019-11-29 | 2020-11-27 | Absorbent article comprising lotion composition and the lotion composition |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP7233356B2 (en) |
| CN (1) | CN112870426A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003012490A (en) * | 2001-07-02 | 2003-01-15 | Uni Charm Corp | Absorptive article and lotion for the same |
| JP2004217640A (en) * | 2002-12-27 | 2004-08-05 | Kao Corp | Skin detergent composition |
| JP2012057275A (en) * | 2010-09-10 | 2012-03-22 | Daiwabo Holdings Co Ltd | Hydrophilic synthetic fiber, fiber aggregate, product for skin contact and fiber treatment agent |
| JP2013155467A (en) * | 2012-01-31 | 2013-08-15 | Daiwabo Holdings Co Ltd | Hydrophilic synthetic fiber, fiber aggregate, product coming in contact with skin and treatment agent for hydrophilic fiber |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6416509B2 (en) * | 2014-06-06 | 2018-10-31 | ユニ・チャーム株式会社 | Absorbent articles |
| JP6531514B2 (en) * | 2014-07-02 | 2019-06-19 | 東洋紡株式会社 | Emulsified composition |
| JP6688454B2 (en) * | 2018-06-01 | 2020-04-28 | 東洋紡株式会社 | Synthetic fiber, fiber treatment agent, and use thereof |
-
2019
- 2019-11-29 JP JP2019217370A patent/JP7233356B2/en active Active
-
2020
- 2020-11-27 CN CN202011358216.7A patent/CN112870426A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003012490A (en) * | 2001-07-02 | 2003-01-15 | Uni Charm Corp | Absorptive article and lotion for the same |
| JP2004217640A (en) * | 2002-12-27 | 2004-08-05 | Kao Corp | Skin detergent composition |
| JP2012057275A (en) * | 2010-09-10 | 2012-03-22 | Daiwabo Holdings Co Ltd | Hydrophilic synthetic fiber, fiber aggregate, product for skin contact and fiber treatment agent |
| JP2013155467A (en) * | 2012-01-31 | 2013-08-15 | Daiwabo Holdings Co Ltd | Hydrophilic synthetic fiber, fiber aggregate, product coming in contact with skin and treatment agent for hydrophilic fiber |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2021084906A (en) | 2021-06-03 |
| JP7233356B2 (en) | 2023-03-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101282708B (en) | External preparation for skin containing a phosphorlated saccharide | |
| JP5406708B2 (en) | Cosmetic composition for skin whitening comprising a combination of a sugar fatty acid ester and a plant extract of Walteria indica or Pisumsativum | |
| CN101583338B (en) | Skin lightening composition for hyperpigmented skin | |
| DE102005063062A1 (en) | Cosmetic or dermatological composition for topical treatment of the skin comprises two soya protein hydrolyzates and a wheat protein hydrolyzate | |
| JP2002520511A (en) | Use of PIT emulsion | |
| JP2005139070A (en) | Skin cosmetic | |
| DE102004032734A1 (en) | Prebiotic substances for deodorants | |
| KR20100021611A (en) | Cosmetic compositions comprising sclareolide and hesperidin methyl chalcone | |
| EP1450760A2 (en) | Itch-relieving cosmetic and dermatological preparations | |
| CN111511366A (en) | Ascorbic acid and/or external composition containing salt thereof | |
| DE102005063178A1 (en) | Cosmetic sunscreen compositions based on lamellar emulsions | |
| ES2428027T3 (en) | Composition comprising adenosine monophosphate for the treatment of melasma | |
| DE102008054118A1 (en) | Active ingredient combination for the treatment of mature skin I | |
| EP1938784A2 (en) | Pre-treatment agent for protecting the scalp | |
| AU2002238988B2 (en) | Sugar intake promoters | |
| CN107613945B (en) | Genistein methyl ether-containing nanoliposome, preparation method thereof and cosmetic composition comprising same | |
| EP2451434A2 (en) | Active-ingredient combination for treating mature skin ii | |
| JP5399701B2 (en) | Whitening skin external preparation and skin whitening method | |
| KR100698356B1 (en) | Skin cosmetics | |
| ES2394610T3 (en) | Fluidizable emulsion concentrates | |
| EP2633887B1 (en) | Novel agent combination for efficient anti-wrinkle effect | |
| SK106599A3 (en) | Skin care product | |
| CN112870426A (en) | Absorbent article comprising lotion composition and the lotion composition | |
| DE102005026357A1 (en) | Topical cosmetic and dermatological composition containing alkylurea and other active agent, useful for treating e.g. ageing of the skin and pigmentation disorders | |
| GB1578066A (en) | Pharmaceutical and cosmetic compositions based on elastin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |